Trade HELP anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Cybin Inc. (HELP) is trading at US$12.18, down 8.01% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$919.83M. Over the past 52 weeks, HELP has traded between US$3.76 and US$14.35. On Syfe you can trade HELP with $0 commission and add it to your watchlist.
| Previous close | US$13.24 |
|---|---|
| Market cap | US$919.83M |
| 52-week range | US$3.76 – US$14.35 |
| Volume | 1.45M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Cybin Inc.
Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.
Year: 2020
--Wells Fargo Initiates Cybin at Overweight With CA$22.56 Price Target
Jul 27, 12:13 PM · MT Newswires
Helus Pharma Completes Enrollment in Phase 3 Study for Depression Treatment
Jul 21, 4:06 PM · MT Newswires
Helus Pharma Closes $50 Million Underwritten Offering
Jun 25, 1:50 PM · MT Newswires
Cybin Inc. (HELP) stock is trading at US$12.18, -8.01% from the previous close of US$13.24.
The market cap for Cybin Inc. (HELP) stock is approximately US$919.83M.
The 52-week high for Cybin Inc. (HELP) stock is US$14.35.
The 52-week low for Cybin Inc. (HELP) stock is US$3.76.
Cybin Inc. (HELP) does not currently pay a dividend.
Stay on top of HELP
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
